Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke.

Conclusion. In cancer-associated stroke patients, treatment with enoxaparin may be more effective than treatment with warfarin for lowering the D-dimer levels. Future prospective studies are warranted to show that enoxaparin is better than warfarin for secondary prevention in cancer-associated stroke. PMID: 26064116 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/26064116?dopt=Abstract

Source: Journal of Oncology - June 15, 2015 Category: Cancer & Oncology Tags: J Oncol Source Type: research